Sunday, May 16, 2010

Absorbable gelatin

U.S. BRAND NAMES — Gelfilm®; Gelfoam®

PHARMACOLOGIC CATEGORY
Hemostatic Agent

DOSING: ADULTS — Hemostasis: Local: Apply packs or sponges dry or saturated with sodium chloride. When applied dry, hold in place with moderate pressure. When applied wet, squeeze to remove air bubbles. The powder is applied as a paste prepared by adding approximately 4 mL of sterile saline solution to the powder.

DOSING: PEDIATRIC — Refer to adult dosing.

DOSING: ELDERLY — Refer to adult dosing.

DOSAGE FORMS — Excipient information presented when available (limited, particularly for generics); consult specific product labeling.

Film, ophthalmic (Gelfilm®): 25 mm x 50 mm (6s)

Film, topical (Gelfilm®): 100 mm x 125 mm (1s)

Powder, topical (Gelfoam®): 1 g

Sponge, dental (Gelfoam®): Size 4 (12s)

Sponge, topical (Gelfoam®):
Size 50 (4s)
Size 100 (6s)
Size 200 (6s)
Size 2 cm (1s)
Size 6 cm (6s)
Size 12-7 mm (12s)

DOSAGE FORMS: CONCISE
Film, ophthalmic:
Gelfilm®: 25 mm x 50 mm (6s)

Film, topical:
Gelfilm®: 100 mm x 125 mm (1s)

Powder, topical:
Gelfoam®: 1 g

Sponge, dental:
Gelfoam®: Size 4 (12s)

Sponge, topical:
Gelfoam®:
Size 50 (4s)
Size 100 (6s)
Size 200 (6s)
Size 2 cm (1s)
Size 6 cm (6s)
Size 12-7 mm (12s)

GENERIC EQUIVALENT AVAILABLE — No

USE — Adjunct to provide hemostasis in surgery; open prostatic surgery

ADVERSE REACTIONS SIGNIFICANT — 1% to 10%: Local: Infection and abscess formation

CONTRAINDICATIONS — Should not be used in closure of skin incisions since they may interfere with the healing of skin edges

WARNINGS / PRECAUTIONS
Disease-related concerns: Infection: Do not use in the presence of infection; if signs or symptoms of infection or abscess develop in an area where placed, reoperation may be necessary to remove material and allow drainage. Postpartum bleeding/menorrhagia: Do not use to control postpartum bleeding or menorrhagia.

Other warnings/precautions: Appropriate use: Do not overpack, product expands by absorbing fluid. Sterilization: Do not sterilize by heat.

DRUG INTERACTIONS — There are no known significant interactions.

PREGNANCY RISK FACTOR — No (show table) data reported

No comments: